Terns Pharmaceuticals shares owned by UBS Group
Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Terns Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Terns Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Terns Pharmaceuticals by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $7.3M | 973k | 7.51 |
| 2025-06-30 | $4.4M | 1.2M | 3.73 |
| 2025-03-31 | $2.6M | 933k | 2.76 |
| 2024-12-31 | $2.2M | 402k | 5.54 |
| 2024-09-30 | $579k | 69k | 8.34 |
| 2024-06-30 | $595k | 87k | 6.81 |
| 2024-03-31 | $412k | 63k | 6.56 |
| 2023-12-31 | $704k | 109k | 6.49 |
| 2023-09-30 | $108k | 22k | 5.03 |
| 2023-06-30 | $464k | 53k | 8.75 |
| 2023-03-31 | $67k | 5.7k | 11.84 |
| 2022-09-30 | $22k | 3.7k | 6.00 |
| 2021-12-31 | $27k | 3.8k | 7.15 |
| 2021-03-31 | $56k | 2.5k | 22.00 |